INS and prediabetes syndrome: All this together emphasizes the additive effect of combined therapies in physiopathology of prediabetes; therapies that may improve insulin sensitivity, like metformin and lifestyle, and therapies that can improve pancreatic islet function, like DPP-IV inhibitors, and highlights the better impact that these combined therapies may have in T2D prevention39,51.